Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|May 7, 2025
Kinase-Targeted Therapies for GlioblastomaMaria Salbini, Alessia Formato, Maria Patrizia Mongiardi, et al.Pharmaceutics|December 28, 2021
Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug RepositioningStefania Olla, Maristella Steri, Alessia Formato, et al.Molecules (Basel, Switzerland)|October 14, 2023
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic ProbesEleonora Colombo, Stefania Olla, Cristina Minnelli, et al.Biomolecules|April 27, 2024
The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway ActivationCaterina Veroni, Stefania Olla, Maria Stefania Brignone, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 23, 2018
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the <i>CYP4X1</i> geneAnna Poleggi, Sven van der Lee, Sabina Capellari, et al.Cancers|December 23, 2022
Characterization of Glioblastoma Cells Response to RegorafenibMaria Patrizia Mongiardi, Mariachiara Buccarelli, Alessia Formato, et al.Cancer Medicine|October 8, 2024
N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of GlioblastomaAlessia Formato, Maria Salbini, Elisa Orecchini, et al.Science Translational Medicine|January 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Svetlana Bezukladova, Farina Windener, et al.Pageof 1